Teva (TEVA) Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, announced a partnership with actor, comedian and advocate, Will Forte, to increase awareness of Huntington’s disease, HD. “We believe that progress starts with understanding, and that means listening to the real relationships and experiences that define the HD community every day,” said Heather DeMyers, Vice President, U.S. Innovative Medicines Marketing at Teva. “Will and Doug’s story captures the perseverance of so many families impacted by this disease. Their experience is one of inspiration, hope, and the importance of community – embodying the values of Teva’s work with Honestly HD as we strive to bring greater empathy and awareness to those navigating this disease.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- AI Daily: Nvidia invests $2B in CoreWeave
- Drugmakers use AI to help progress through trials, submissions, Reuters says
- Options Volatility and Implied Earnings Moves This Week, January 26 – January 30, 2026
- TEVA Earnings this Week: How Will it Perform?
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 25